163 related articles for article (PubMed ID: 29733545)
1. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Ding F; Wang D; Li XK; Yang L; Liu HY; Cui W; Liu ZH; Che YQ
Thorac Cancer; 2018 Jul; 9(7):827-835. PubMed ID: 29733545
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
Katono K; Sato Y; Kobayashi M; Saito K; Nagashio R; Ryuge S; Igawa S; Nakashima H; Shiomi K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Masuda N
Oncol Res Treat; 2017; 40(10):594-602. PubMed ID: 28950283
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
4. CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.
Zhou X; Cheng Z; Chen H; Shi S; Wang X; Orang M; Zhao J
J Cell Biochem; 2018 Dec; 119(12):10186-10194. PubMed ID: 30132978
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
[TBL] [Abstract][Full Text] [Related]
6. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
7. Loss of S100A14 expression is associated with the progression of adenocarcinomas of the small intestine.
Kim G; Chung JY; Jun SY; Eom DW; Bae YK; Jang KT; Kim J; Yu E; Hong SM
Pathobiology; 2013; 80(2):95-101. PubMed ID: 23038644
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
9. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
10. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
11. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
12. The role of S100A14 in epithelial ovarian tumors.
Cho H; Shin HY; Kim S; Kim JS; Chung JY; Chung EJ; Chun KH; Hewitt SM; Kim JH
Oncotarget; 2014 Jun; 5(11):3482-96. PubMed ID: 24939856
[TBL] [Abstract][Full Text] [Related]
13. Protein overexpression and gene amplification of cellular mesenchymal-epithelial transition factor is associated with poor prognosis in micropapillary-predominant subtype pulmonary adenocarcinoma.
Zhang J; Sun J; Zhang Z; Liang X; Luo Y; Wu S; Liang Z
Hum Pathol; 2018 Feb; 72():59-65. PubMed ID: 29128478
[TBL] [Abstract][Full Text] [Related]
14. S100A14 serum level and its correlation with prognostic factors in breast cancer.
Al-Ashkar N; Zetoune AB
J Egypt Natl Canc Inst; 2020 Sep; 32(1):37. PubMed ID: 32984913
[TBL] [Abstract][Full Text] [Related]
15. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
16. A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer.
Diamantopoulou A; Mantas D; Kostakis ID; Agrogiannis G; Garoufalia Z; Kavantzas N; Kouraklis G
In Vivo; 2020; 34(1):321-330. PubMed ID: 31882495
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
Wu G; Dong Z; Dong Y; Chen Y; Zhu H; Ding D; Cui Y; Wang Y; Xu Y; Chen H
Cancer Sci; 2024 May; 115(5):1492-1504. PubMed ID: 38476086
[TBL] [Abstract][Full Text] [Related]
18. Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
Zhao CC; Chen J; Niu RF; Liu Y; Zhang CG
Oncol Rep; 2018 Dec; 40(6):3392-3404. PubMed ID: 30272365
[TBL] [Abstract][Full Text] [Related]
19. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
20. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
